These MVs carry not only CD38, but also CD39, CD73 and CD203a ectoenzymes, inhibitory complement receptors CD55 and CD59, the checkpoint inhibitor PD-L1, and the myeloma differentiation marker CD138 (21). This evidence concerns the gene CD38 and plasma cell myeloma.